-+ 0.00%
-+ 0.00%
-+ 0.00%

Sky Labs signs KRW 4.9 billion CART O2 supply deal with Daewoong Pharmaceutical

PUBT·10/01/2026 01:54:01
Sky Labs signs KRW 4.9 billion CART O2 supply deal with Daewoong Pharmaceutical
  • Sky Labs signed a KRW 4.9 billion supply contract with Daewoong Pharmaceutical for CART O2 ring-type SpO2 devices in South Korea.
  • Contract value equals 61.74% of Sky Labs’ 2025 standalone revenue of KRW 7,935,865,376.
  • Contract runs from Sept. 30, 2026 to Nov. 30, 2026.
  • Payment due within 30 days of invoice; no upfront payment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sky Labs Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261001900122), on October 01, 2026, and is solely responsible for the information contained therein.